Abstract
The vitamin D analogue MC 1288 (20-epi-1α,25-dihydroxycholecalciferol) was tested here for its possible immunosuppressive properties in vivo using different rat transplantation models. MC 1288, in a dose of 0.1 μg/kg daily, administered intraperitoneally for 10 days, was found to be effective in prolonging cardiac allograft survival. Untreated recipients rejected their grafts around day 8 while MC 1288 treatment delayed rejection until day 22 (P<0.001). Addition of the immunostimulatory drug LS-2616 (Linomide) reduced the immunosuppressive effect of MC 1288 and rejection occurred around day 11. The immunosuppressive effect of MC 1288 on rejection following small bowel transplantation was determined by measuring the amounts of hyaluronan (HA) secreted into the intestinal lumen. On day 6 post-transplantation the amounts of intraluminal HA in untreated animals was 29.2±5.3 ng/min and cm, while in MC 1288-treated animals it was just 5.0±1.6 ng/min and cm (P<0.01). We conclude that MC 1288 has immunosuppressive effects that may make it suitable for the prevention of graft rejection.
Similar content being viewed by others
References
Bengtsson M, Simonsson B, Carlsson K, Nilsson B, Smedmyr B, Termander B, Öberg G, Tötterman TH (1992) Stimulation of NK cell, T cell, and monocyte function by the novel immunomodulator Linomide after autologous bone marrow transplantation. Transplantation 53: 882–888
Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57: 1308–1310
Binderup L, Latini S, Binderup E, Bretting C, Calverley M, Hansen K (1991) 20-Epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42: 1569–1575
Gannedahl G, Wanders A, Carlsson M, Tufveson G (1993) 15-Deoxyspergualin effects in rat heart allograft transplantation — relation to dose, timing, and cyclosporine. Transplantation 55: 455–456
Jacobsson J, Wahlberg J, Frödin L, Odlind B, Tufveson G (1989) Organ flush out solutions and cold storage preservation solutions. Effect on organ cooling and post ischemic erythrocyte trapping in kidney grafts. An experimental study in the rat. Scand J Urol Nephrol 23: 219–222
Johnsson C, Tufveson G (1994) The immunomodulator LS-2616 (Linomide) more effectively than sensitization of the donor enhances graft-versus-host reaction after small bowel transplantation. Transplant Immunol 2: 56–60
Johnsson C, Hällgren R, Tufveson G (1993) Recovery of hyaluronan during perfusion of small bowel transplantation reflects rejection. Transplantation 55: 477–479
Kalland T, Alm G, Stålhandske T (1985) Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator. J Immunol 134: 3956–3961
Koren R, Liberman UA, Maron L, Novogrodsky A, Ravid A (1989) 1,25-Dihydroxyvitamin D3 acts directly on human lymphocytes and interferes with the cellular response to interleukin-2. Immunopharmacology 18: 187–194
Larsson E-L, Joki A, Stålhandske T (1987) Mechanism of action of the new immunomodulator LS 2616 on T cell responses. Int J Immunopharmacol 9: 425–431
Lemire JM, Archer DC (1991) 1,25-Dihydroxyvitamin D3 prevents in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87: 1103–1107
Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134: 3032–3035.
Lemire JM, Archer DC, Khulkarni A, Ince A, Uskokovic MR, Stepkowski S (1992) Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 397-1. Transplantation 54: 762–763
Olausson M, Mjörnstedt L, Lindholm L, Brynger H (1984) Non-suture organ grafting to the neck vessels in rats. Acta Chir Scand 150: 463–467
Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181–1183
Reichel H, Koeffler HP, Tobler A, Norman AW (1987) 1α,25-Dihydroxyvitamin D3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 84: 3385–3389
Rigby WFC, Stacy T, Fanger MW (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74: 1451–1455
Rigby WFC, Noelle RJ, Krause K, Fanger MW (1985) The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol 135: 2279–2286
Rigby WFC, Denome S, Fanger MW (1987) Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79: 1659–1664
Tabata T, Suzuki R, Kikunami K, Matsushita Y, Inoue T, Inoue T, Okamoto T, Miki T, Nishizawa Y, Morii H (1986) The effect of 1α-hydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patients. J Clin Endocrinol Metab 63: 1218–1221
Tabata T, Shoji T, Kikunami K, Matsushita Y, Inioue T, Tanaka S, Hino M, Miki T, Nishizawa T, Morii H (1988) In vivo effect of 1α-hydroxyvitamin D3 on interleukin-2 production in hemodialysis patients. Nephron 50: 295–298
Tengblad A (1980) Quantitative analysis of hyaluronate in nanogram amounts. Biochem J 185: 101–105
Tobler A, Gasson J, Reichel H, Norman AW, Koeffler HP (1987) Granulocytemacrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by 1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest 79: 1700–1705
Tsoukas CD, Watry D, Escobar SS, Provvedini DM, Dinarello CA, Hustmyer FG, Manolagas SC (1989) Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 69: 127–133
Vieth R (1990) The mechanisms of vitamin D toxicity. Bone Miner 11: 267–272
Wallander J, Holtz A, Larsson E, Gerdin B, Läckgren G, Tufveson G (1988) Small-bowel transplantation in the rat with a nonsuture cuff technique: technical and immunological considerations. Transpl Int 1: 135–139
Wanders A, Larsson E, Gerdin B, Tufveson G (1989) Abolition of the effect of cyclosporine on rat cardiac allograft rejection by the new immunomodulator LS-2616 (Linomide). Transplantation 47: 216–217
Wientroub S, Winter CC, Wahl SM, Wahl LM (1989) Effect of vitamin D deficiency on macrophage and lymphocyte function in the rat. Calcif Tissue Int 44: 125–130
Author information
Authors and Affiliations
About this article
Cite this article
Johnsson, C., Tufveson, G. MC 1288 — A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts. Transpl Int 7, 392–397 (1994). https://doi.org/10.1007/BF00346032
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00346032